Table 3 Comparison of baseline characteristics in low and high CD8+ PD1+ AML patients
From: Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
Variable | Total number (n = 57) | Low CD8+ PD-1+ (n = 28) | High CD8+ PD-1+ (n = 29) | Statistic | p |
|---|---|---|---|---|---|
Gender, n (%) | χ2 = 0.449 | 0.503 | |||
Male | 27 (47.37) | 12 (42.86) | 15 (51.72) | ||
Female | 30 (52.63) | 16 (57.14) | 14 (48.28) | ||
Risk, n (%) | – | 0.138 | |||
Low risk | 5 (15.62) | 3 (17.65) | 2 (13.33) | ||
Medium risk | 9 (28.12) | 7 (41.18) | 2 (13.33) | ||
High risk | 18 (56.25) | 7 (41.18) | 11 (73.33) | ||